Opportunities lie in developing efficient CAPA systems for pharma and medical device industries, enhancing root cause analysis, implementing effective solutions, and ensuring consistent product ...

Here are three important regulatory changes affecting parenteral packaging that pharmaceutical companies need to be aware of ...

Lipid-based nanoparticles are pivotal in modern medicine, improving drug delivery and mRNA therapies through innovative ...

Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...